
Join the Excitement: Anavex Life Sciences to Present at H.C. Wainwright BioConnect Investor Conference at NASDAQ!
Join the Excitement: Anavex Life Sciences to Present at H.C. Wainwright BioConnect Investor Conference at NASDAQ! Description: NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease,…